arsenic trioxide has been researched along with Squamous Cell Carcinoma of Head and Neck in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Aminishakib, P; Asadi, M; Derakhshan, S; Farzaneh, P; Ganjibakhsh, M; Pirzadeh, F; Rahrotaban, S; Tavakoli Shiraji, S | 1 |
An, L; Li, X; Yang, X | 1 |
de Faria, GP; Dos Santos Ferreira, AC; Kwee, JK; Pereira, DL | 1 |
Boyko-Fabian, M; Budach, V; Distel, L; Niehr, F; Tinhofer, I | 1 |
Goux, D; Guillamin, M; Hamza-Chaffai, A; Khlifi, R; Sichel, F; Trabelsi, F | 1 |
5 other study(ies) available for arsenic trioxide and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
The effect of aflibercept and arsenic trioxide on the proliferation, migration and apoptosis of oral squamous cell carcinoma in vitro.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Endoglin; Humans; Mouth Neoplasms; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor B | 2021 |
Arsenic trioxide induced endoplasmic reticulum stress in laryngeal squamous cell line Hep-2 cells.
Topics: Activating Transcription Factor 4; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Head and Neck Neoplasms; Heat-Shock Proteins; Humans; Laryngeal Neoplasms; Oxides; Squamous Cell Carcinoma of Head and Neck; Transcription Factor CHOP | 2014 |
Autophagy interplays with apoptosis and cell cycle regulation in the growth inhibiting effect of Trisenox in HEP-2, a laryngeal squamous cancer.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Oxides; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck | 2015 |
Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Breaks, Double-Stranded; Drug Resistance, Neoplasm; ErbB Receptors; Head and Neck Neoplasms; Humans; Oxides; Protein Kinase Inhibitors; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Protein p53 | 2014 |
Cytotoxicity and genotoxicity effects of arsenic trioxide on SQ20B human laryngeal carcinoma cells.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Comet Assay; DNA Damage; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Oxides; Squamous Cell Carcinoma of Head and Neck | 2017 |